Insight Molecular Diagnostics (IMDX) Non-Current Debt (2017 - 2021)
Insight Molecular Diagnostics (IMDX) posted Non-Current Debt of $178000.0 for Q3 2021, down 67.1% sequentially from $541000.0 in Q2 2021, and down 91.38% YoY from $2.1 million in Q3 2020.
Insight Molecular Diagnostics (IMDX) Non-Current Debt (2017 - 2021) Analysis & Trends
Insight Molecular Diagnostics has reported Non-Current Debt for 5 years, with the latest figure at $178000.0 in Q3 2021.
- Quarterly Non-Current Debt fell 91.38% year-over-year to $178000.0 in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $178000.0 (down 91.38% YoY) and the FY2020 annual result came in at $1.5 million, down 20.84% from the prior year.
- Non-Current Debt slipped to $178000.0 in Q3 2021 per IMDX's latest filing, from $541000.0 in the prior quarter.
- Over five years, Non-Current Debt peaked at $2.6 million in Q2 2020 and troughed at $159000.0 in Q1 2019.
- A 5-year average of $1.1 million and a median of $1.1 million in 2017 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2020 and 2021: Non-Current Debt surged 884.28% in 2020, then sank 91.38% in 2021.
- Over 5 years, Non-Current Debt stood at $1.1 million in 2017, then plunged by 67.57% to $347000.0 in 2018, then surged by 448.99% to $1.9 million in 2019, then decreased by 20.84% to $1.5 million in 2020, then plunged by 88.2% to $178000.0 in 2021.
- According to Business Quant data, Non-Current Debt over the past three periods registered $178000.0, $541000.0, and $951000.0 for Q3 2021, Q2 2021, and Q1 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 42.28 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 25.15 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 299.87 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 3.05 Bn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 13.71 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | - |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 1.49 Bn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 2.04 Bn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 5.64 Bn |
| 10 | Insight Molecular Diagnostics | 172.42 Mn | 143.49 Mn | 15,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 178,000.00 |
| Jun 30, 2021 | 541,000.00 |
| Mar 31, 2021 | 951,000.00 |
| Dec 31, 2020 | 1.51 Mn |
| Sep 30, 2020 | 2.07 Mn |
| Jun 30, 2020 | 2.62 Mn |
| Mar 31, 2020 | 1.57 Mn |
| Dec 31, 2019 | 1.91 Mn |
| Mar 31, 2019 | 159,000.00 |
| Dec 31, 2018 | 347,000.00 |
| Sep 30, 2018 | 531,000.00 |
| Jun 30, 2018 | 713,000.00 |
| Mar 31, 2018 | 893,000.00 |
| Dec 31, 2017 | 1.07 Mn |
| Sep 30, 2017 | 1.24 Mn |
| Jun 30, 2017 | 1.42 Mn |
| Mar 31, 2017 | 1.59 Mn |